Literature DB >> 32081201

Fine-tuning of antiviral innate immunity by ubiquitination.

Yi Zheng1, Chengjiang Gao2.   

Abstract

The innate immune system represents the first defense line of the host following viral infection. The infection triggers the recognition of pathogen-associated molecular patterns (PAMPs) from the viruses by pattern recognition receptors (PRRs) of the host cell. The interaction between viral PAMPs and PRRs evokes a sophisticated signal transduction system and eventually promotes the expression of type I interferons (IFNs) and proinflammatory cytokines. Ubiquitination plays an indispensable role in fine-tuning almost every single step of this signaling cascade given on its versatile functions. Ubiquitin ligases and deubiquitinases (DUBs), which cooperatively and accurately regulate the dynamic and reversible ubiquitination process, are the master regulators of antiviral signaling. In this review, we concentrate on summarizing the ubiquitin ligases and DUBs that modulate the central signaling molecules in antiviral innate immunity. Especially, we emphasize the ones that were identified by the immunologists from China.
© 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antiviral innate immunity; Deubiquitinase; E3 ubiquitin ligase; Signaling transduction; Ubiquitination

Mesh:

Substances:

Year:  2019        PMID: 32081201     DOI: 10.1016/bs.ai.2019.11.004

Source DB:  PubMed          Journal:  Adv Immunol        ISSN: 0065-2776            Impact factor:   3.543


  11 in total

1.  UFL1 promotes antiviral immune response by maintaining STING stability independent of UFMylation.

Authors:  Yijie Tao; Shulei Yin; Yang Liu; Chunzhen Li; Yining Chen; Dan Han; Jingyi Huang; Sheng Xu; Zui Zou; Yizhi Yu
Journal:  Cell Death Differ       Date:  2022-07-23       Impact factor: 12.067

Review 2.  Toll-like receptor 3 (TLR3) regulation mechanisms and roles in antiviral innate immune responses.

Authors:  Yujuan Chen; Junhong Lin; Yao Zhao; Xianping Ma; Huashan Yi
Journal:  J Zhejiang Univ Sci B       Date:  2021-08-15       Impact factor: 3.066

Review 3.  Intracellular mono-ADP-ribosyltransferases at the host-virus interphase.

Authors:  Bernhard Lüscher; Maud Verheirstraeten; Sarah Krieg; Patricia Korn
Journal:  Cell Mol Life Sci       Date:  2022-05-10       Impact factor: 9.207

Review 4.  TRIMming Type I Interferon-Mediated Innate Immune Response in Antiviral and Antitumor Defense.

Authors:  Ling Wang; Shunbin Ning
Journal:  Viruses       Date:  2021-02-11       Impact factor: 5.818

Review 5.  Type I Interferons and Malaria: A Double-Edge Sword Against a Complex Parasitic Disease.

Authors:  Xiao He; Lu Xia; Keyla C Tumas; Jian Wu; Xin-Zhuan Su
Journal:  Front Cell Infect Microbiol       Date:  2020-12-02       Impact factor: 5.293

6.  USP18 positively regulates innate antiviral immunity by promoting K63-linked polyubiquitination of MAVS.

Authors:  Jinxiu Hou; Lulu Han; Ze Zhao; Huiqing Liu; Lei Zhang; Chunhong Ma; Fan Yi; Bingyu Liu; Yi Zheng; Chengjiang Gao
Journal:  Nat Commun       Date:  2021-05-20       Impact factor: 14.919

7.  Interplay of the ubiquitin proteasome system and the innate immune response is essential for the replication of infectious bronchitis virus.

Authors:  Nishant Kumar Ojha; Jingjing Liu; Tianqi Yu; Chengxiu Fang; Jiyong Zhou; Min Liao
Journal:  Arch Virol       Date:  2021-05-26       Impact factor: 2.685

8.  GSNOR facilitates antiviral innate immunity by restricting TBK1 cysteine S-nitrosation.

Authors:  Qianjin Liu; Tianle Gu; Ling-Yan Su; Lijin Jiao; Xinhua Qiao; Min Xu; Ting Xie; Lu-Xiu Yang; Dandan Yu; Ling Xu; Chang Chen; Yong-Gang Yao
Journal:  Redox Biol       Date:  2021-10-18       Impact factor: 11.799

Review 9.  The Role of Deubiquitinases in Virus Replication and Host Innate Immune Response.

Authors:  Qinglin Zhang; Qizhen Jia; Wenying Gao; Wenyan Zhang
Journal:  Front Microbiol       Date:  2022-02-24       Impact factor: 5.640

Review 10.  Potential Inhibitors Targeting Papain-Like Protease of SARS-CoV-2: Two Birds With One Stone.

Authors:  Haihai Jiang; Peiyao Yang; Jin Zhang
Journal:  Front Chem       Date:  2022-02-23       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.